Correction Notice: Survodutide for Adults with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease: Findings from the SYNCHRONIZE-MASLD Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
-
By
-
Lee M. Kaplan
-
Elena Startseva
-
Carel W. le Roux
-
Sean Wharton
-
Biykem Bozkurt
-
Daniel F. Mazo
-
Jessica von Schlippenbach
-
Sandra González Maldonado
-
Samina Ajaz Hussain
-
Guy W. Neff
-
Yaneicy Gonzalez Rojas
-
Charles Smith
-
Ramy Younes
-
Arun J. Sanyal
-
August 25, 2026